Fig. 2From: Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database studyAll-cause mortality of the patients with eGFR ≥ 30 mL/min/1.73 m2 who received levosimendan versus dobutamine alone before (a) and after (b) propensity score matchingBack to article page